--- title: "The 28-Day Rule for GLP-1 Vials, and When It Applies | Peptyn" description: "The 28-day rule comes from USP standards for preserved multi-dose vials. Most GLP-1 labels set a different number. Here is how to find yours." canonical: "https://peptyn.orlyn.ai/articles/28-day-rule-glp1-vial" last-updated: "2026-08-16" --- # The 28-Day Rule for GLP-1 Vials, and When It Applies *The 28-day rule comes from USP standards for preserved multi-dose vials. Most GLP-1 labels set a different number. Here is how to find yours.* Educational · Not medical advice · 18+ You punctured the vial. Somewhere along the way you picked up that you have 28 days. The number is real and it comes from a real standard. If what you are holding is an FDA-approved GLP-1 product, it is probably not your number, and the one that applies is printed on something already in the box. Published 15 August 2026 · 10 min read · 6 sources Here is where 28 days comes from, why it usually does not govern a GLP-1 product, and why the one thing no label can supply is the part you have to write down yourself. ## Where the number comes from The 28-day figure lives in USP General Chapter 797, the United States Pharmacopeia's standard for compounded sterile preparations. The relevant sentence reads:[1] > Multiple-dose containers (e.g., vials) are formulated for removal of portions on multiple occasions because they usually contain antimicrobial preservatives. The BUD after initially entering or opening (e.g., needle-punctured) multiple-dose containers is 28 days (see Antimicrobial Effectiveness Testing 51) unless otherwise specified by the manufacturer. A word on which version of the chapter that is, because it matters for an article telling you to read sources. The USP bulletin carrying that text was posted in April 2020, and its stated purpose was to confirm that the chapter as last revised in 2008 remained official after revisions published in 2019 were sent back to committee on appeal. A revised chapter 797 later became official on November 1, 2023, and its full text sits behind the USP-NF subscription.[6] So the sentence above is genuinely USP's, and it is the version that was official and freely readable when that bulletin was posted. It is not a quote from the current paywalled chapter. If the exact present-day wording is what you need, a pharmacist has USP-NF access and you do not. Three things in that sentence get dropped almost everywhere the rule is repeated. **It is about preserved containers.** A multiple-dose vial can be entered repeatedly because it contains an antimicrobial preservative. That is the mechanism. The rule is not a general statement about punctured containers, it is a statement about the category of container built to be punctured more than once. **The 28 points at another chapter.** The cross-reference is to Antimicrobial Effectiveness Testing, chapter 51. The number is a default tied to how long a preservative system is expected to keep performing, not a measurement of how quickly anything grows in your particular drug. **The default yields to the label.** "Unless otherwise specified by the manufacturer" is the operative clause, and it runs in both directions. A manufacturer can specify longer than 28 days, or shorter, or a period that counts from something other than first puncture. That last clause is where most people's actual answer lives. ## What your label probably says instead The FDA-approved labels for these products are public on DailyMed. They do not agree with each other, and the in-use periods they set are not 28 days. The label for the Ozempic pen states that after first use the pen "can be stored for 56 days" at controlled room temperature or in a refrigerator. The patient section is blunter: the pen in use "should be disposed of (thrown away) after 56 days, even if it still has OZEMPIC left in it. Write the disposal date on your calendar."[2] The Victoza pen label sets a different period. After first use, "the pen can be stored for 30 days," and the patient section states the pen "should be thrown away 30 days after you start using it."[3] Zepbound runs on a different structure again. Its single-dose pen and single-dose vial are refrigerated, and if kept at room temperature the label says to "discard single-dose pen and single-dose vial after a total of 21 days at room temperature." The multi-dose vial carries three conditions at once: throw it away "after a total of 30 days at room temperature, 30 days after first use, or after taking 4 weekly doses, even if there is medicine left in it."[4] So: 56, 30, 21, and a three-way whichever-comes-first. The 28-day rule is a default for a category of compounded preparation. The products most people on a GLP-1 are actually holding have been specified otherwise, which is exactly the case USP 797 hands back to the manufacturer. A 28 that does appear on one of these labels is worth reading closely, because it is not the USP 28. The Ozempic single-dose prefilled syringe, a different presentation from the pen, is stored refrigerated, and the label adds that "if needed, the syringe can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days," then says to "discard the OZEMPIC syringe after use."[2] That number is a temperature-excursion allowance for an unopened single-dose device. It has nothing to do with repeated entry into a preserved vial. Same digits, different clock, different reason. Notice also what the Ozempic label instructs the patient to do. Write the date down. The manufacturer assumes a record will exist, because the packaging cannot keep one. ## Read the word "total" Two of those periods count from first use. One of them, the 21 days on Zepbound's single-dose presentations, is written as "a total of 21 days at room temperature." That word is load-bearing. A period stated as a total accumulates across separate excursions rather than restarting each time the product goes back into the cold. A clock that counts from first use and a clock that counts accumulated time out of the refrigerator are different clocks, and a product can be running both. This is worth checking on your own label rather than assuming, because it changes what you would even need to record. A first-use clock needs one date. A cumulative-exposure clock needs every excursion. ## Where 28 days does show up in a peptide protocol If your protocol involves bacteriostatic water, the 28-day default is suddenly relevant again, for the reason USP 797 gave. Bacteriostatic Water for Injection is labeled as containing "0.9% (9 mg/mL) or 1.1% (11 mg/mL) of benzyl alcohol added as a bacteriostatic preservative," supplied in "a multiple-dose container from which repeated withdrawals may be made to dilute or dissolve drugs for injection."[5] That preservative is the thing that makes repeat entry contemplated at all. It is the kind of container 797's sentence is about, though the chapter is written for compounding personnel rather than for whoever is holding the vial. Those two percentages are worth a second look, because they are not a range. On this label they are two different presentations with their own order codes: the How Supplied table ties 9 mg/mL to the 30 mL plastic vial and 11 mg/mL to the 20 mL fill in a 30 mL glass vial, from the same distributor.[5] Two containers that read as the same thing on a shelf are not necessarily carrying the same amount of preservative, which is one more reason the specific container is the thing worth writing down rather than the product name. But the reconstituted vial is not the same object as either of its inputs. It is not the lyophilised compound and it is not the water, and its in-use period is not something you can read off the water's label or derive from the compound's. If a pharmacy prepared it, the pharmacy assigns the beyond-use date and puts it on the label it hands you. If what you are holding has no assigned date on it, there is no beyond-use date to look up. There is an unanswered question, and the people who can answer it are the prescriber and the pharmacist. ## "It still looks clear" It is a reasonable-sounding thought, and it inverts what the labels actually say. The labels ask for a visual check and state it as a disqualifier. Ozempic: "Inspect OZEMPIC visually before use. It should appear clear and colorless. Do not use OZEMPIC if particulate matter and coloration is seen."[2] Zepbound: "Do not use ZEPBOUND if particulate matter or discoloration is seen."[4] Both sentences take an option away when something is visible. Neither says that a clear solution is cleared for use, and neither ties the visual check to the in-use period, which the same labels state separately and independently. USP 797 points the same direction. Its instruction to compounding personnel handling manufactured multi-dose vials is that "When contaminants or abnormal properties are suspected or observed in MDVs, such MDVs shall be discarded."[1] Suspicion alone is enough to discard. The absence of suspicion is not stated as grounds to keep. A look can rule something out. It was never specified as a way to rule something in. ## The two dates, and which one nobody records There are two clocks and they measure different things. The printed expiration date is the manufacturer's date for the product sealed, unopened, and stored as labeled. The Ozempic label states the condition explicitly: unused pens "may be used until the expiration date ('EXP') printed on the label, if kept in the refrigerator."[2] The date is real, and it is conditional on the product remaining in the state the date assumes. The in-use period is a second, shorter clock, and it starts on an event rather than on a printed date. Nothing on the packaging records when that event happened. The carton does not know when you first used it. The pharmacy does not know. The manufacturer wrote the number but cannot start the clock. That gap is the entire job of a record. ## What a usable record actually contains Four things make a container's history reconstructable later: - **Which compound and which container.** A question about a specific batch needs to be able to reach a specific container. - **The date of first entry, written the day it happened.** A date reconstructed three weeks later from memory is a recollection. A date written on the day is a record. This is the only field where the timing of the writing matters as much as the content. - **The in-use period you were given, copied as stated, and where it came from.** The label or the pharmacy. Copying it verbatim preserves the structure, including whether it counts from first use, from accumulated temperature exposure, from a dose count, or from more than one at once. - **The date you stopped using it.** It closes the interval, which is what makes the record answerable rather than open-ended. The Zepbound multi-dose vial shows why the third bullet is not pedantry. Its label runs three counters at once: total days at room temperature, days since first use, and doses taken.[4] A note that says only "opened on the 3rd" has captured one of the three. Whichever counter runs out first is the one that ends the vial, and the two that accumulate cannot be reconstructed afterwards from a single date. None of this requires an app. A marker and the vial's own label do the job. What an app adds is that the entry is timestamped when you make it and does not depend on you finding the same marker next month. ## How Peptyn holds this A vial in Peptyn stores the compound, the vial's mg, the bacteriostatic water in ml, and the date you mixed it. That date is stamped on the day you save the mix rather than typed in afterwards, which is the property the second bullet above is actually asking for. The Stack screen then lists the vial with its mg and its water volume, or marks it unmixed. The other half of that list is not in the app. There is no field for the in-use period your label states, and none for the date you stopped using the container, so those two belong on the vial itself or on paper beside it. Nor does the app derive a date: it does not compute a beyond-use date from the mix date, it does not know what your label says, and it does not compute anything about your dose. That limit is deliberate. The moment software starts assigning beyond-use dates, it is making a call that belongs to whoever prepared and prescribed the thing. ## Questions worth taking to a prescriber or pharmacist - What in-use period applies to this specific product, and where is it stated? - Does that period count from first use, from accumulated time out of refrigeration, from a number of doses, or from more than one of those at once? - If this was compounded, what beyond-use date was assigned, and is it on the label I received? - What should I do if it spent time outside its labeled temperature range? - What do you want me to do with it once the period is up? The last one matters most, because it puts the decision back where it belongs and gets you an answer before you need it rather than while you are standing in front of the fridge. ## What a record can and cannot do A record does not make anything safe. It does not extend a period, shorten one, or say anything about whether a container is fit to use. Writing a date changes nothing about what is in the vial. What it does is make one specific question answerable: when did this start. That question has no other source. The manufacturer wrote the number. The pharmacy dispensed the container. Neither of them was in the room when the clock started. You were the only instrument present. This article describes where a published number comes from and quotes what public labels say. It is not instructions, and it does not tell you what to do with anything you are holding. That decision belongs to the prescriber and the pharmacist who can see your label and your circumstances. ## References 1. United States Pharmacopeia. General Chapter 797, Pharmaceutical Compounding: Sterile Preparations. Revision Bulletin, official May 1, 2020. 2. OZEMPIC (semaglutide) injection, solution. FDA-approved prescribing information and patient labeling, via DailyMed, U.S. National Library of Medicine. 3. VICTOZA (liraglutide) injection. FDA-approved prescribing information and patient labeling, via DailyMed, U.S. National Library of Medicine. 4. ZEPBOUND (tirzepatide) injection, solution. FDA-approved prescribing information and patient labeling, via DailyMed, U.S. National Library of Medicine. 5. BACTERIOSTATIC WATER for Injection, USP. FDA-approved labeling, via DailyMed, U.S. National Library of Medicine. 6. United States Pharmacopeia. General Chapter 797 programme page, recording that the revised chapter became official on November 1, 2023. ## Keep reading - [Your lot number, and how to check it](https://peptyn.orlyn.ai/articles/glp1-recall-lot-number) Where the code lives on a pen, vial and carton, how to search FDA enforcement records, and which channel takes which report. - [The glossary that will not do your math](https://peptyn.orlyn.ai/articles/peptide-glossary) Plain definitions from lyophilized to 503A, with sources. It defines every term and stops where the arithmetic starts. - [The GLP-1 tracking spreadsheet: eight fields that matter](https://peptyn.orlyn.ai/articles/glp1-tracker-spreadsheet) The eight columns worth keeping, what each one answers months later, and the three moments a spreadsheet stops being the right tool. - [Who can actually see your GLP-1 data](https://peptyn.orlyn.ai/articles/glp1-app-data-privacy) What HIPAA does not cover, which law applies instead, and a checkable method for reading any app's privacy label. This article is educational. It does not recommend doses, schedules, or products, and it is not medical advice. Every factual claim above is linked to its source. Questions about your own protocol belong with the prescriber who wrote it. --- Source: